Table of Contents
Table of Contents
Foreword
About the Contributors
Acknowledgments
Introduction
Chapter 1 – Defining, Classifying and Staging Chronic Kidney Disease (pp. 1-10)
Morgan Grams, MD (Division of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA)
Chapter 2 – Selecting the Right Estimated Glomerular Filtration Rate (pp. 11-16)
Andrew S. Levey, MD (William B. Schwartz Division of Nephrology, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA)
Chapter 3 – Reversing the Reversible (pp. 17-26)
Stephen Z. Fadem, MD (Clinical Professor of Medicine, Department of Medicine, Division of Nephrology, Baylor College of Medicine, Medical Director, Houston Kidney Center/DaVita Integrated Service Network, Chief Medical Officer, Kidney Associates, Houston, Texas, USA)
Chapter 4 – Preventing Chronic Kidney Disease: An Overview (pp. 27-42)
Stephen Z. Fadem, MD (Clinical Professor of Medicine, Department of Medicine, Division of Nephrology, Baylor College of Medicine, Medical Director, Houston Kidney Center/DaVita Integrated Service Network, Chief Medical Officer, Kidney Associates, Houston, Texas, USA)
Chapter 5 – Imaging in Chronic Kidney Disease (pp. 43-60)
Barry Toombs, MD (Clinical Associate Professor, Baylor College of Medicine, Singleton Associates, CHI St. Lukes Hospital and Texas Heart Institute, Houston, Texas, USA)
Chapter 6 – Screening for Chronic Kidney Disease: Critical Analysis (pp. 61-66)
Richard J. Glassock, MD (Geffen School of Medicine at UCLA, USA)
Chapter 7 – Using Guidelines in the Approach to the Chronic Kidney Disease Patient (pp. 67-72)
Garabed Eknoyan, MD (Renal Section, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA)
Chapter 8 – Acute Kidney Injury: Classification and Prognosis (pp. 73-82)
Biruh Workeneh, MD (Division of Nephrology, Baylor College of Medicine, Houston, TX, USA)
Chapter 9 – Nutritional Therapy for Patients with Chronic Kidney Disease (pp. 83-98)
William E. Mitch, MD (Nephrology Division, Department of Medicine, Bayor College of Medicine, Houston, Texas, USA)
Chapter 10 – Medications to Avoid in Chronic Kidney Disease (pp. 99-112)
Sarah McDaniel, PharmD and William M. Bennett, MD (Legacy Transplant Services, Good Samaritan Medical Center, Portland, OR, USA)
Chapter 11 – The Role of Blood Pressure Control and Anti-Hypertensive Therapy in Preventing Kidney Disease Progression (pp. 113-122)
Jordana B. Cohen, MD, and Raymond R. Townsend, MD (Renal, Electrolyte, and Hypertension Division, University of Pennsylvania, Philadelphia, Pennsylvania, USA)
Chapter 12 – The Approach to Glomerular Disease in Chronic Kidney Disease (pp. 123-142)
Wooin Ahn, MD, Andrew Bomback, MD and Gerald Appel, MD (Clinical Medicine, Columbia University College of Physicians and Surgeons, New York, New York, USA)
Chapter 13 – The Approach to Hematuria in Chronic Kidney Disease (pp. 143-154)
Wooin Ahn, MD, Andrew Bomback, MD and Gerald Appel, MD (Clinical Medicine, Columbia University College of Physicians and Surgeons, New York, New York, USA)
Chapter 14 – Diabetic Nephropathy: Current Clinical Challenges (pp. 155-162)
Mark E. Williams, MD, and Sylvia E. Rosas, MD (Kidney and Hypertension Section, Joslin Diabetes Center and Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA)
Chapter 15 – Focal Segmental Glomerulosclerosis and Collapsing Glomerulopathy Syndromes (pp. 163-172)
Jeffrey B. Kopp, MD (Kidney Diseases Branch, NIDDK, NIH, NIH, Bethesda, MD, USA)
Chapter 16 – APOL1 Kidney Disease (pp. 173-180)
Jeffrey B. Kopp, MD and Cheryl A. Winkler, PhD (Kidney Diseases Branch, NIDDK, NIH, NIH, Bethesda, MD, USA)
Chapter 17 – Uric Acid and Chronic Kidney Disease (pp. 181-192)
Anuradha Wadhwa, MD and Richard J. Johnson, MD (Division of Renal Disease and Hypertension, Loyola University Medical Center, Maywood, IL, USA, Division of Nephrology, Hines VA Hospital, Hines, IL, USA, Division of Kidney Diseases and Hypertension, University of Colorado Denver, Aurora CO, USA, and Division of Nephrology, Eastern Colorado Health Care System, Department of Veteran Affairs, Denver, CO, USA)
Chapter 18 – Other Causes of Chronic Kidney Disease (pp. 192-206)
Anjay Rastogi, MD., PhD, and Mehdi Momen, MD (UCLA David Geffen School of Medicine, Director, UCLA Dialysis, Los Angeles, California, USA)
Chapter 19 – When to Refer the Chronic Kidney Disease Patient to the Nephrologist (pp. 207-212)
William H. Herman, MD, MPH, and Richard Hellman, MD (Professor of Diabetes, Internal Medicine, and Epidemiology, University of Michigan, Director of the Michigan Center for Diabetes Translational Research)
Chapter 20 – Transitions of Care in a Complex Patient Population: The Case of Chronic Kidney Disease (pp. 213-216)
Todd F. Griffith, MD, and J. Edward Hartle II, MD (Metrolina Nephrology Associates, PA, Charlotte, NC.; Clinical Assistant Professor, University of North Carolina School of Medicine, and others)
Chapter 21 – Disease Management Strategies in Chronic Kidney Disease (pp. 217-220)
Robert J. Kossmann, MD (Vice President, Fresenius Medical Care-USA)
Chapter 22 – Approach to the Psychological Aspects of Chronic Kidney Disease (pp. 221-228)
Emily Steinberg Fadem, MD (Assistant Clinical Professor, Psychiatry Icahn School of Medicine at Mount Sinai, New York, New York, USA)
Chapter 23 – Whether to Initiate Dialysis Therapy in Geriatric Patients with Advanced Chronic Kidney Disease (pp. 229-236)
Eli A. Friedman, MD (Department of Medicine, State University of New York, Downstate Medical Center, Brooklyn, New York, USA)
Chapter 24 – Cardiovascular Disease in Chronic Kidney Disease (pp. 237-246)
Peter A. McCullough, MD (Baylor University Medical Center, Baylor Jack and Jane Hamilton Heart and Vascular Hospital, Dallas, TX, The Heart Hospital, Plano, TX, USA)
Chapter 25 – Anemia in Chronic Kidney Disease (pp. 247-256)
Muzzaffar Hussain, MD and Michael J Germain, MD (Baystate Medical Center/Tufts University School of Medicine, Springfield, MA, USA)
Chapter 26 – Metabolic Acidosis and Management with Dietary Alkali (pp. 257-270)
Donald E. Wesson, MD (Texas A&M Health Sciences Center College of Medicine, Temple, TX, USA)
Chapter 27 – The Low Serum Albumin in Chronic Kidney Disease (pp. 271-278)
Allon N. Friedman, MD (Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA)
Chapter 28 – Chronic Kidney Disease – Mineral Bone Disorder (pp. 279-288)
Ruth L. Wintz, MD, and Antonio Duran, MD (Clinical Assistant Professor of Medicine at Baylor College of Medicine, Weil Cornell Medical College and University of Texas Medical Branch at Galveston, Houston, Texas, USA, and Universidad Autónoma de Baja California, Tijuana, Baja California, Mexico)
Chapter 29 – Keeping Patients Employed (pp. 289-292)
Robert Provenzano, MD (Vice President of Medical Affairs, DaVita Healthcare Partners, Inc., Detroit, MI, USA)
Chapter 30 – Assessing and Preparing the Patient for Future ESRD Modalities (pp. 293-304)
Martin J. Schreiber, MD and Thomas A. Golper, MD (Department Nephrology and Hypertension, Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA, and Division of Nephrology and Hypertension, Vanderbilt Center for Kidney Diseases, Nashville, TN, USA)
Chapter 31 – Prognostication Tools As a Guide to Appropriate Integration of Palliative Care into Chronic Kidney Disease Treatment Plans (pp. 305-318)
Jennifer S. Scherer, MD and Michael J. Germain, MD (New York University School of Medicine, Division of Geriatric Medicine and Palliative Care and Division of Nephrology, NY, USA, and Professor of Medicine Tufts University School of Medicine, Baystate Medical Center, MA, USA)
Chapter 32 – When Renal Replacement Therapy May Not Be the Best Option (pp. 319-326)
Rebecca Schmidt, DO (West Virginia University, USA)
Chapter 33 – Assessing the Chronic Kidney Disease Patient‘s Vessels for Hemodialysis Vascular Access (pp. 327-334)
Vo D. Nguyen, MD (Fistula First & Catheter Last-Emeritus Advisory Group member, Memorial Nephrology Associates, Olympia, WA, USA)
Chapter 34 – Peritoneal Dialysis (pp. 335-340)
John Burkart, MD (Wake Forest University School of Medicine)
Chapter 35 – Home Hemodialysis (pp. 341-348)
Robert S. Lockridge Jr. MD (Lynchburg Nephrology Physicians, Retired Clinical Associate Professor of Nephrology University of Virginia)
Chapter 36 – In-Center Nocturnal Hemodialysis (pp. 349-354)
Rachel Fissell, MD (Assistant Professor of Medicine, Division of Nephrology and Hypertension, Vanderbilt University School of Medicine
Nashville, Tennessee, USA)
Chapter 37 – Staff Assisted In-Center Hemodialysis (pp. 356-362)
Douglas S. Johnson, MD, Toros Kapoian, MD and Klemens B. Meyer, MD (Dialysis Clinic, Inc., Nashville, TN, USA, Rutgers –Robert Wood Johnson Medical School, New Brunswick, NJ, USA, and Division of Nephrology, Tufts Medical Center, Boston, MA, USA)
Chapter 38 – Preemptive Kidney Transplantation (pp. 363-368)
Horacio E. Adrogue, MD (Associate Professor, Renal Diseases and Hypertension, Medical Director, Kidney and Pancreas Transplant Center, University of Texas Health Science Center at Houston, Houston, Texas, USA
Index
Audience:
Clinicians: doctors, medical students, residents, fellows, advanced nurse practitioners, physician assistants and nephrologists regardless of training or place of work, dialysis facility and health plan medical directors
Nonmedical: Hospital and Managed Care administrators, Clinic managers. Attorneys.
